This includes regular clinical examination and serum calcitonin and carcinoembryonic antigen (CEA) levels for MTC, as well as serum thyroglobulin (Tg) and anti-thyroglobulin antibody levels for PTC with ultrasound of the neck. The gene discussed is CALCA; the disease is medullary thyroid gland carcinoma.